Episurf Medical AB (publ)

Episurf Medical AB (publ)

EPIS-B · ST · Healthcare / Medical Devices

0.0579SEK-0.00 (-0.52%)

Price History

Full chart

Market Stats

Previous Close0.0582
Open0.0575
Day Range0.055 – 0.0579
52-Week Range0.0245 – 0.29
Volume8.30M
Market Cap1.18B
P/E (TTM)0.00
Forward P/E19.34
EPS-0.09
Dividend Yield0.00%
Beta0.90
50-Day Avg0.0699
200-Day Avg0.0695

About

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It provides Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The company also offers Epioscopy to identify and visualize femoral knee joint cartilage and bone lesions, and tibia, as well as defects on the cruciate ligaments and menisci; Epiguide, a surgical drill guide; and µiFidelity, a web platform for order management, communication, personalized design, and surgical pre-planning. In addition, it is developing Episealer MTP implant, an implant for the MTP joint of the big toe in the foot. Further, the company offers Talus Osteotomy Guide (TOG) that is designed to fit on the patient's distal tibia using CT and MRI images; MRI protocol to ensure correct damage assessment, 3D visualization, and device design; and Damage Marking Report (DMR) that enables 3D visualization of damage in the joint surface and underlaying bone defects, as well as other findings relevant when selecting the right treatment for the patient. It has logistics and warehouse properties in Helsinki and Kerava. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMs. Katarina Flodström Ph.D.
  • Employees22
  • HeadquartersKarlavAegen 60, Stockholm, Sweden, 114 49, Sweden
  • Websitehttps://episurf.com

Leadership

  • Dr. Leif RydConsultant, Member of Clinical Advisory Board & Director · b. 1949
  • Ms. Katarina Flodström Ph.D.Deputy CEO & Head of Medical Technology Operations · b. 1975
  • Mr. Jens AnderssonCEO & Director · b. 1973
  • Ms. Sanja BatljanChief Financial Officer · b. 1967
  • Mr. Fredrik ZetterbergMarketing Director · b. 1975
  • Ms. Ylva BondeHead of Quality & Regulatory Affairs · b. 1979
  • Ms. Petra Widen LindhHead of Property Management
  • Mr. Christian OlofssonDeputy CEO & Head of Business Development
  • Mr. Patrick JamnikPresident of Episurf Medical Inc · b. 1983

Financials

Income Statement

Currency: SEK2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue----37.92K173.03K1.02M2.41M2.49M4.00M4.90M5.00M6.50M6.60M10.30M13.00M13.50M
Growth (%)-----+356.34%+487.46%+136.67%+3.52%+60.63%+22.50%+2.04%+30.00%+1.54%+56.06%+26.21%+3.85%
Cost of Revenue---11.57M16.98M21.30M46.01M-1.61M60.54M3.30M4.50M5.10M4.80M4.20M104.40M2.30M71.50M
Gross Profit----11.57M-16.94M-21.13M-44.99M4.01M-58.05M700.00K400.00K-100.00K1.70M2.40M-94.10M10.70M-58.00M
Gross Margin-----44690.69%-12211.91%-4426.53%166.72%-2330.92%17.50%8.16%-2.00%26.15%36.36%-913.59%82.31%-429.63%
Operating Expense---4.74M6.33M12.13M-1.02M65.72M3.11M58.20M69.20M63.80M71.10M79.40M700.00K87.90M2.40M
Operating Income-540.53K-2.78M-4.98M-16.30M-23.28M-33.26M-43.97M-61.71M-61.15M-57.50M-68.80M-63.90M-69.40M-77.00M-94.80M-77.20M-60.40M
Operating Margin-----61398.03%-19223.27%-4326.25%-2565.20%-2455.65%-1437.50%-1404.08%-1278.00%-1067.69%-1166.67%-920.39%-593.85%-447.41%
EBITDA-429.02K-2.66M-4.17M-15.20M-21.78M-31.15M-41.74M-57.61M-56.91M-52.40M-64.30M-58.00M-63.80M-71.40M-87.70M-69.00M-49.20M
EBITDA Margin-----57445.24%-18005.03%-4106.36%-2394.85%-2285.23%-1310.00%-1312.24%-1160.00%-981.54%-1081.82%-851.46%-530.77%-364.44%
Net Income-540.24K-2.79M-4.46M-15.77M-22.86M-32.91M-43.97M-61.67M-61.09M-57.80M-70.60M-64.60M-69.50M-77.30M-94.80M-76.00M-58.20M
Net Income Margin-----60282.45%-19022.82%-4326.25%-2563.48%-2453.31%-1445.00%-1440.82%-1292.00%-1069.23%-1171.21%-920.39%-584.62%-431.11%
R&D------466.18K1.61M3.71M9.70M5.50M4.10M6.90M11.60M8.30M5.30M5.50M
R&D as % of Total Revenue------45.86%66.72%148.95%242.50%112.24%82.00%106.15%175.76%80.58%40.77%40.74%
Interest Expense003.73K4412.75K6.48K6872.94K2.96K700.00K700.00K700.00K200.00K700.00K900.00K1.00M600.00K
Interest Expense % of Total Revenue----7.24%3.75%0.07%0.12%0.12%17.50%14.29%14.00%3.08%10.61%8.74%7.69%4.44%

Balance Sheet

Currency: SEK2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.20M11.27M50.55M27.91M76.42M43.24M118.20M60.30M93.29M54.80M57.60M185.40M270.60M197.20M104.30M97.80M59.80M
Total Liabilities445.19K1.54M2.04M3.52M4.81M4.39M8.27M11.61M7.71M10.00M16.20M15.90M17.80M19.50M19.80M14.00M12.30M
Total Equity759.76K9.74M48.50M24.39M71.61M38.85M109.93M48.70M85.57M44.80M41.40M169.50M252.80M177.70M84.50M83.80M47.50M
Cash295.29K7.02M39.61M23.08M68.87M34.49M103.96M42.30M71.28M28.30M25.30M155.00M237.90M155.30M57.90M50.50M7.10M
Total Debt-------1.17M-2.80M5.90M3.90M2.90M6.30M5.20M2.30M6.80M
Net Debt-295.29K-7.02M-39.61M-23.08M-68.87M-34.49M-103.96M-41.13M-71.28M-25.50M-19.40M-151.10M-235.00M-149.00M-52.70M-48.20M-300.00K

Cash Flow

Currency: SEK2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.00M-3.91M-15.05M-20.64M-31.66M-38.04M-56.10M-61.38M-52.30M-59.20M-54.10M-59.70M-69.50M-84.80M-71.40M-55.30M
Investing Cash Flow-3.04M-6.71M-1.49M-3.64M-2.87M-7.38M-5.56M-7.48M-9.70M-5.50M-5.10M-6.50M-11.20M-9.50M-7.60M-6.70M
Financing Cash Flow11.76M43.22M-70.08M150.13K114.89M97.80M97.84M19.10M61.60M188.80M149.20M-1.90M-3.00M71.60M18.60M
Capital Expenditure3.04M6.71M1.49M3.64M2.87M7.38M5.56M7.48M9.70M5.50M4.60M7.00M11.30M9.50M7.60M55.30M
Free Cash Flow-5.04M-10.63M-16.54M-24.28M-34.53M-45.42M-61.66M-68.86M-62.00M-64.70M-58.70M-66.70M-80.80M-94.30M-79.00M-62.00M
FCF to OCF252.33%271.48%109.92%117.64%109.06%119.39%109.92%112.18%118.55%109.29%108.50%111.73%116.26%111.20%110.64%112.12%

Earnings

Report DateMar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013May 28, 2014Sep 3, 2014Nov 7, 2014Feb 20, 2015May 6, 2015Aug 21, 2015Nov 6, 2015Feb 23, 2016May 3, 2016Aug 10, 2016Nov 4, 2016Feb 20, 2017May 15, 2017Aug 18, 2017Nov 10, 2017Feb 23, 2018Apr 27, 2018Jul 20, 2018Oct 26, 2018Feb 8, 2019Apr 18, 2019Jul 19, 2019Oct 25, 2019Feb 7, 2020Apr 24, 2020Jul 17, 2020Oct 23, 2020Feb 19, 2021Apr 29, 2021Jul 16, 2021Oct 29, 2021Feb 11, 2022Apr 29, 2022Jul 15, 2022Nov 16, 2022Feb 17, 2023Apr 28, 2023Jul 14, 2023Oct 27, 2023Feb 9, 2024Apr 24, 2024Jul 12, 2024Oct 25, 2024Feb 7, 2025Apr 10, 2025Jul 11, 2025Oct 24, 2025Feb 6, 2026May 4, 2026Jun 30, 2026
EPS Estimate-------0.96-1.21-0.72-0.69-0.91-0.92------------------------------------------
EPS Actual-0.18-0.20-0.14-0.17-0.23-0.26-0.91-1.01-0.52-1.09-0.71-0.89-0.43-0.61-0.56-0.68-0.51-0.35-0.35-0.39-0.34-0.41-0.32-0.38-0.33-0.42-0.19-0.21-0.19-0.08-0.08-0.08-0.08-0.08-0.07-0.08-0.06-0.07-0.07-0.09-0.09-0.11-0.08-0.08-0.08-0.06-0.02-0.03-0.03-0.03-0.01-0.01-0.01-0.04
Surprise------5.21%16.53%27.78%-57.97%21.98%3.26%------------------------------------------
Timing------Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap1.18B
Enterprise Value1.42B
Trailing P/E0.00
Forward P/E19.34
Price / Sales45.08
Price / Book1.94
EPS-0.09
Book Value0.086
Revenue (TTM)26.10M
Gross Profit (TTM)12.60M
EBITDA-47.60M
Profit Margin0.00%
Operating Margin65.85%
Return on Equity-91.07%
Return on Assets-3.91%
Shares Outstanding16.07B
Shares Float4.34B
Beta0.90
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jul 20, 20111:6